PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 2, 2024Frontiers in Oncology4 citationsOpen Access

Testing calpain inhibition in tumor endothelial cells: novel targetable biomarkers against glioblastoma malignancy

View Full Paper

Authors

LGLaura GuarnacciaSNStefania Elena NavoneLBLaura Begani

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Guarnaccia et al. (2024) studied this question.

synapsesocial.com/papers/68e5dae2b6db6435875704a3https://doi.org/10.3389/fonc.2024.1355202
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Data from Glioblastoma vascular plasticity limits effector T-cell infiltration and is blocked by cAMP activation2024
  2. 2System biology approach to identify the novel biomarkers in glioblastoma multiforme tumors by using computational analysis2024 · 5 citations
  3. 3Circulating tumor RNA and exosomes as disease prognosis and therapy effectivity novel markers in case of malignant gliomas in adults2024 · 1 citations
  4. 4P18.08.B IDENTIFICATION OF NOVEL THERAPEUTIC OPTIONS FOR THE TREATMENT OF GLIOBLASTOMA USING A HIGH-THROUGHPUT LIVE-IMAGING-BASED DRUG SCREENING PLATFORM2025
  5. 5Identification of Potential Therapeutic Targets and Biomarkers for Glioblastomas Through Integrative Analysis of Gene Expression Data2024